News
- December 07, 2012 | Antiviral Therapy
Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals.
Major initiatives of wider hepatitis C testing and promoting linkage to treatment for those found to be infected are the development of tests of identifying recent and active infections.
Read Article > - December 07, 2012 | Antiviral Therapy
Testing and reporting practices for improved management of hepatitis C
Patients with hepatitis C have experienced recent improvements in treatment and disease management. These gains will be fully realized once surveillance of new cases is improved and reporting standards are harmonized.
Read Article > - December 07, 2012 | Antiviral Therapy
Changing strategies for hepatitis C testing
Dr. Chon Gee Teo writes in this editorial that the prospects for the eventual elimination of hepatitis C virus is dependent on the minimizing the complexity and costs associated with testing and identifying anti-HCV immunoglobin G.
Read Abract > - December 06, 2012 | Journal of Hepatology
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
Taiwan’s increasing consumption of alcohol and its relationship to high prevalence of hepatitis B and hepatocellular carcinoma is examined.
Read Study > - November 23, 2012 | CNN
Top 5 Baby Boomer Health Trends
CNN’s special on baby boomers lists five top trends in health and wellness, including hepatitis C testing.
Read Article > - November 01, 2012 | American Clinical Laboratory Association (Press Release)
CDC to Boomers: "Get a Hepatitis C Test"
The American Clinical Laboratory Association (ACLA) reminds baby boomers about the importance of getting tested for hepatitis C. “Having the test could help save your life," said Alan Mertz, president of the ACLA.
Read Press Release > - October 22, 2012 | Wall Street Journal
Connecting Patients With Experimental Drugs
FDA’s compassionate-use, or expanded access, program gives relief to hepatitis C patient, Dr. Nisha Gupta. Dr. Gupta was featured on the Faces of Hepatitis (http://www.viralhepatitisaction.org/node/227).
Read Article > - October 22, 2012 | BMJ Open
Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials
Antiviral therapy study suggests a potential reduction in risk of hepatocellular carcinoma in chronic hepatitis C.
Read Study > - October 18, 2012 | PharmaTimes
Hep C and melanoma drugs claim Prix Galien USA awards
Merck and Vertex shared the award for best pharmaceutical agent at the Prix Galien USA awards for their hepatitis drugs.
Read Article > - October 01, 2012 | Clinical Gastroenterology and Hepatology
Process of Care for Hepatitis C Infection Is Linked to Treatment Outcome and Virologic Response
A cohort study of hepatitis C patients, as identified from the Veteran Administration’s HCV Clinical Case Registry, indicated that optimum care delivered before treatment yielded increased rates of treatment and sustained virologic response (SVR).
Read Study >